17 November 2021 Protego Biopharma Raises $51 Million Series A Financing to Advance the Treatment of Protein Misfolding Diseases read more
24 June 2021 Vida Ventures Closes $825 Million Vida III Fund to Advance Transformative Biomedical Innovations read more
21 June 2021 Centessa Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs read more
20 October 2020 Praxis Precision Medicines Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares read more
10 August 2020 Dyne Therapeutics Announces $115 Million Financing to Advance Pipeline of Modern Oligonucleotide Therapeutics for Serious Muscle Diseases read more
